Notification That Annual Report Will Be Submitted Late (nt 10-k)
April 01 2019 - 5:07PM
Edgar (US Regulatory)
|
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
|
OMB
APPROVAL
|
OMB Number: 3235-0058
|
Expires: February 28, 2022
|
Estimated
average burden hours per response.. 2.50
|
|
SEC FILE NUMBER
|
001-38185
|
|
CUSIP NUMBER
|
|
(Check
one):
|
[X]
Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ]
Form N-SAR [ ] Form N-CSR
|
|
For
Period Ended:
|
December
31, 2018
|
|
[ ]
Transition Report on Form 10-K
|
|
|
|
[ ]
Transition Report on Form 20-F
|
|
|
|
[ ]
Transition Report on Form 11-K
|
|
|
|
[ ]
Transition Report on Form 10-Q
|
|
|
|
[ ]
Transition Report on Form N-SAR
|
|
For
the Transition Period Ended:
|
Read
Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
|
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART
I — REGISTRANT INFORMATION
Pressure
BioSciences, Inc.
|
Full
Name of Registrant
|
|
|
Former
Name if Applicable
|
|
14
Norfolk Avenue
|
Address
of Principal Executive Office
(Street and Number)
|
|
South
Easton, MA 02375
|
City,
State and Zip Code
|
PART
II — RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check box if appropriate)
[X]
|
(a)
|
The
reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
|
|
(b)
|
The
subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR,
or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject
quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof will be
filed on or before the fifth calendar day following the prescribed due date; and
|
|
|
(c)
|
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART
III — NARRATIVE
State
below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion
thereof, could not be filed within the prescribed time period.
PRESSURE
BIOSCIENCES, INC. (the “Registrant”) was unable, without unreasonable effort or expense, to file its Annual Report
on Form 10-K for the year ended December 31, 2018 (the “Annual Report”) by the April 1, 2019 filing date applicable
to smaller reporting companies due to a delay experienced by the Registrant in completing its financial statements and other disclosures
in the Annual Report. This delay was related to the departure of the Registrant’s Chief Financial Officer on February 22,
2019.
As
a result, the Registrant is still in the process of compiling required information to complete the Annual Report and its independent
registered public accounting firm requires additional time to complete its review of the financial statements for the period ended
December 31, 2018 to be incorporated in the Annual Report. The Registrant anticipates that it will file the Annual Report no later
than the fifteenth calendar day following the prescribed filing date.
PART
IV — OTHER INFORMATION
(1)
|
Name
and telephone number of person to contact in regard to this notification
|
|
Richard
T. Schumacher
|
|
(508)
|
|
230-1828
|
|
(Name)
|
|
(Area
Code)
|
|
(Telephone
Number)
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required
to file such report(s) been filed? If answer is no, identify report(s).
|
|
Yes
[X] No [ ]
|
|
|
(3)
|
Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
|
Yes
[ ] No [X]
|
|
|
|
If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
|
PRESSURE
BIOSCIENCES, INC.
(Name
of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date:
April 1, 2019
|
By:
|
/s/
Richard T. Schumacher
|
|
Name:
|
Richard
T. Schumacher
|
|
Title:
|
President
and Chief Executive Officer
|
Pressure Biosciences (CE) (USOTC:PBIO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pressure Biosciences (CE) (USOTC:PBIO)
Historical Stock Chart
From Sep 2023 to Sep 2024